lorazepam has been researched along with flumazenil in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (38.71) | 18.7374 |
1990's | 31 (33.33) | 18.2507 |
2000's | 20 (21.51) | 29.6817 |
2010's | 6 (6.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bailey, J; Glue, P; Hudson, A; Nutt, DJ; Wilson, S | 1 |
Byrnes, JJ; Galpern, WR; Greenblatt, DJ; Miller, LG; Shader, RI | 1 |
Miller, LG | 1 |
Galpern, WR; Greenblatt, DJ; Lumpkin, M; Miller, LG; Shader, RI | 1 |
Galpern, WR; Greenblatt, DJ; Miller, LG; Shader, RI | 1 |
Doenicke, A; Greim, M; Juhl, G; Rampf, U; Suttmann, H | 1 |
Morse, WH; Teeple, ES; Wettstein, JG | 2 |
Kadiwar, RM; Pillay, R | 1 |
Wettstein, JG | 3 |
Lopez, A; Rebollo, J | 1 |
Greenblatt, DJ; Miller, LG; Roy, RB; Shader, RI; Summer, WR | 1 |
Broks, P; Preston, GC; Stahl, SM; Traub, M; Ward, CE | 1 |
Chauvin, M; Costes, H; Duvaldestin, P; Guirimand, F; Lebrault, C | 1 |
Hellevuo, K; Kiianmaa, K; Korpi, ER | 1 |
Klotz, U | 1 |
Dunton, AW; Hendler, J; McGrath, J; Pitman, V; Schwam, E; Siegel, J | 1 |
File, SE | 2 |
Ator, NA; Griffiths, RR | 2 |
Johanson, CE; Schuster, CR | 1 |
Ackenheil, M; Doenicke, A; Dorow, R; Duka, T; Noderer, J | 1 |
Spealman, RD; Wettstein, JG | 2 |
Berenberg, D; Dorow, R; Duka, T; Sauerbrey, N | 1 |
Benkert, O; Heuser, I; Wetzel, H | 2 |
File, SE; Lister, RG | 1 |
Lister, RG; Nutt, DJ | 1 |
Greenblatt, DJ; Miller, LG; Paul, SM; Shader, RI | 1 |
Jensen, LH; Petersen, EN | 2 |
Deutsch, SI; Greenblatt, DJ; Miller, LG; Paul, SM; Shader, RI; Thompson, ML | 1 |
Gwee, MC; Wong, PT; Yoong, YL | 1 |
Dingemanse, J; File, SE; Friedman, HL; Greenblatt, DJ | 1 |
File, SE; Wilks, LJ | 1 |
Costello, MJ; Nutt, DJ | 1 |
Doenicke, A; Dorow, R; Duka, T; Klotz, U | 1 |
Bryere, P; Kaijima, M; Naquet, R; Valin, A | 1 |
De Bonnel, G; De Montigny, C | 1 |
Cepeda, C; Comar, D; Crouzel, M; Guibert, B; Hantraye, P; Kaijima, M; Maziere, M; Naquet, R; Prenant, C; Sastre, J | 1 |
Griffiths, RR; Lamb, RJ | 1 |
Bonetti, EP; Cumin, R; Haefely, WE; Scherschlicht, R | 1 |
Andreason, P; Carson, RE; Cohen, R; Greenblatt, DJ; Herscovitch, P; Johanson, CE; King, C; Matthew, E; Paul, SM; Pettigrew, K | 1 |
Clark, RF; Manoguerra, AS; Sage, TA; Tunget, C | 1 |
Burr, G; Fowler, JS; Hitzemann, R; Lowrimore, P; Overall, J; Pappas, N; Pascani, K; Volkow, ND; Wang, GJ; Wolf, AP | 1 |
Hanania, MM | 1 |
Byrnes, JJ; Greenblatt, DJ; Miller, LG; Shader, RI | 1 |
Burke, TF; Miller, LG; Moerschbaecher, JM | 1 |
Bailine, SH; Bernstein, S; Safferman, A; Vital-Herne, J | 1 |
Ator, NA; Griffiths, RR; Sannerud, CA | 1 |
McLachlan, RS; Sharpe, MD; Sprenger, H | 1 |
Klarlund, R; Metzger, E | 1 |
Finder, RL; Moore, PA | 1 |
al-Tikriti, MS; Baldwin, RM; Bradberry, C; Bremner, JD; During, M; Malison, RT; Seibyl, JP; Sybirska, E; Zea-Ponce, Y; Zoghbi, S | 1 |
Evans, SM; Furman, WR; Griffiths, RR; Guarino, JJ; Liebson, I; Roache, JD; Schwam, EM | 1 |
Bishop, KI; Curran, HV | 2 |
Avanzini, P; Caccavari, R; Chittolini, B; Delsignore, R; Fertonani, G; Gerra, G; Giucasto, G; Zaimovic, A | 1 |
de Zeeuw, RA; Ensing, K; Janssen, MJ; Stegeman, M | 1 |
Bhattacharya, SK; Chakrabarti, A; Glover, V; Sandler, M | 1 |
Larson, JS; Lunn, JJ | 1 |
Roach, JT; Sufka, KJ; Watson, GS | 1 |
Benz, A; Covey, DF; Eisenman, LN; Fields, C; Fu, T; He, Y; Mathews, J; Mennerick, S; Steinbach, JH; Wang, M; Zeng, CM; Zorumski, CF; Zorumski, E | 1 |
Agelink, MW; Andrich, J; Majewski, TB; Mueck-Weymann, M | 1 |
Gong, QH; Gulinello, M; Smith, SS | 1 |
Carter, AR; Cheo-Isaacs, CT; Crooke, JJ; DeLuca, S; DeVine, A; Dubinsky, B; Hochman, C; Jordan, AD; Reitz, AB; Rosenthal, DI; Shank, RP; Vaidya, AH | 1 |
Gulinello, M; Smith, SS | 1 |
Flanigan, J; Olshaker, JS | 1 |
Bisbrown-Chippendale, R; Bullmore, ET; Dirckx, SG; Kerwin, RW; McKenna, PJ; Ooi, C; Pickard, JD; Stephenson, CM; Suckling, J | 1 |
Feeney, A; Grasby, PG; Lingford-Hughes, A; Nutt, DJ; Wilson, SJ | 1 |
Atack, JR; Cook, SM; McKernan, RM; Pym, LJ; Rosahl, T | 1 |
Kazis, A; Kazis, DA; Kimiskidis, VK; Mills, KR; Papagiannopoulos, S; Sotirakoglou, K; Vasiliadis, G; Zara, F | 1 |
Aigbirhio, FI; Atack, JR; Baron, JC; Beech, JS; Clark, JC; Cleij, MC; Fryer, TD; Hargreaves, RJ; Hughes, JL; Scott-Stevens, P | 1 |
France, CP; Javors, MA; McMahon, LR | 1 |
Bullmore, E; Fletcher, P; Kamath, S; McKenna, P; Menzies, L; Ooi, C; Stephenson, C; Suckling, J | 1 |
Gutman, DA; Nemeroff, CB; Owens, MJ; Skelton, KH; Thrivikraman, KV | 1 |
Ahonen, J; Olkkola, KT | 1 |
Darbra, S; Pallarès, M | 1 |
Furst, BA; Kwon, GE; Makhinson, M; Shuff, MK | 1 |
Reti, IM; Wachtel, LE; Ying, H | 1 |
Djordjević, S; Ercegović, GV; Segrt, Z; Stosić, JJ; Vukcević, NP | 1 |
Bailey, AM; Baum, RA; Horn, K; Justice, SN; Lewis, T; Morizio, K; Schultz, A; Weant, K | 1 |
9 review(s) available for lorazepam and flumazenil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chronic benzodiazepine administration: from the patient to the gene.
Topics: Alprazolam; Animals; Benzodiazepines; Clonazepam; Down-Regulation; Drug Tolerance; Flumazenil; Humans; Lorazepam; Mice; Receptors, GABA-A; RNA, Messenger; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Up-Regulation | 1991 |
Flumazenil: US clinical pharmacology studies.
Topics: Adult; Diazepam; Double-Blind Method; Drug Interactions; Female; Flumazenil; Humans; Lorazepam; Male; Memory; Receptors, GABA-A; Triazolam | 1988 |
What can be learned from the effects of benzodiazepines on exploratory behavior?
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Carbolines; Environment; Exploratory Behavior; Flumazenil; Lorazepam; Mice; Motor Activity; Pyrazoles; Rats; Receptors, GABA-A | 1985 |
Delayed onset lorazepam poisoning successfully reversed by flumazenil in a child. Case report and review of the literature.
Topics: Child, Preschool; Female; Flumazenil; Humans; Lorazepam; Poisoning; Sleep Stages; Time Factors | 1995 |
Benzodiazepines for intravenous conscious sedation: agonists and antagonists.
Topics: Anesthesia, Dental; Benzodiazepines; Conscious Sedation; Diazepam; Flumazenil; Humans; Injections, Intravenous; Lorazepam; Midazolam | 1993 |
Comparing drugs for short-term sedation.
Topics: Anesthesia; Benzodiazepines; Conscious Sedation; Diazepam; Flumazenil; Humans; Lorazepam; Midazolam; Pain; Propofol | 1994 |
Midazolam and other benzodiazepines.
Topics: Anesthetics, Intravenous; Animals; Benzodiazepines; Biotransformation; Central Nervous System; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; Humans; Lorazepam; Midazolam; Molecular Structure; Receptors, GABA-A; Structure-Activity Relationship | 2008 |
Review of Intranasally Administered Medications for Use in the Emergency Department.
Topics: Administration, Intranasal; Anesthetics, Dissociative; Anticonvulsants; Antidotes; Antipsychotic Agents; Dexmedetomidine; Emergency Service, Hospital; Fentanyl; Flumazenil; Haloperidol; Humans; Hydromorphone; Hypnotics and Sedatives; Ketamine; Lorazepam; Midazolam; Naloxone; Narcotic Antagonists; Narcotics | 2017 |
15 trial(s) available for lorazepam and flumazenil
Article | Year |
---|---|
Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements.
Topics: Adult; Conscious Sedation; Female; Flumazenil; Flunitrazepam; Humans; Injections, Intravenous; Kinetics; Lorazepam; Male; Radioligand Assay; Receptors, GABA-A; Saccades; Sleep Stages; Thyrotropin-Releasing Hormone | 1992 |
[Beta activation following the intravenous administration of benzodiazepines and the specific antagonist flumazenil (Ro 15-1788)].
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Beta Rhythm; Diazepam; Dose-Response Relationship, Drug; Electroencephalography; Flumazenil; Flunitrazepam; Humans; Injections, Intravenous; Lorazepam; Male; Midazolam; Prospective Studies; Randomized Controlled Trials as Topic; Stimulation, Chemical | 1990 |
Effects of lorazepam on memory, attention and sedation in man: antagonism by Ro 15-1788.
Topics: Adolescent; Adult; Attention; Female; Flicker Fusion; Flumazenil; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Psychomotor Performance; Reaction Time; Visual Acuity | 1989 |
Flumazenil: US clinical pharmacology studies.
Topics: Adult; Diazepam; Double-Blind Method; Drug Interactions; Female; Flumazenil; Humans; Lorazepam; Male; Memory; Receptors, GABA-A; Triazolam | 1988 |
Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788.
Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Blood Pressure; Double-Blind Method; Electrocardiography; Electroencephalography; Flumazenil; Flunitrazepam; Humans; Lorazepam; Male; Norepinephrine; Random Allocation | 1986 |
Amnestic effects of lormetazepam and their reversal by the benzodiazepine antagonist Ro 15-1788.
Topics: Adult; Amnesia; Anti-Anxiety Agents; Benzodiazepines; Cognition; Emotions; Female; Flumazenil; Humans; Lorazepam; Male; Memory | 1987 |
Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Flumazenil; Flunitrazepam; Humans; Kinetics; Lorazepam; Male | 1985 |
Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
Topics: Adolescent; Adult; Drug Interactions; Flumazenil; Hemodynamics; Humans; Injections, Intravenous; Lorazepam; Male; Middle Aged; Reference Values; Respiration; Substance Withdrawal Syndrome | 1993 |
Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil.
Topics: Adolescent; Adult; Attention; Female; Flumazenil; Humans; Lorazepam; Male; Memory; Mental Recall; Middle Aged; Placebo Effect; Receptors, GABA-A; Task Performance and Analysis | 1995 |
Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Flumazenil; GABA Modulators; Humans; Injections, Intravenous; Lorazepam; Male; Substance Withdrawal Syndrome | 1996 |
An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming.
Topics: Adolescent; Adult; Female; Flumazenil; GABA Modulators; Humans; Lorazepam; Male; Memory; Middle Aged; Muscarinic Antagonists; Neuropsychological Tests; Scopolamine | 1998 |
Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam.
Topics: Adult; Autonomic Nervous System; Benzodiazepines; Diazepam; Female; Flumazenil; Heart; Heart Rate; Humans; Injections, Intravenous; Lorazepam; Male; Midazolam; Middle Aged; Preanesthetic Medication; Prospective Studies | 2002 |
GABAergic inhibitory mechanisms for repetition-adaptivity in large-scale brain systems.
Topics: Adult; Arousal; Brain Mapping; Cerebral Cortex; Double-Blind Method; Female; Flumazenil; GABA Agonists; gamma-Aminobutyric Acid; Habituation, Psychophysiologic; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lorazepam; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neural Inhibition | 2003 |
A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist.
Topics: Area Under Curve; Brain; Carbon Isotopes; Drug Interactions; Flumazenil; GABA Modulators; Humans; Isoindoles; Lorazepam; Male; Naphthyridines; Positron-Emission Tomography | 2005 |
Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia.
Topics: Adult; Brain; Cerebral Cortex; Cognition Disorders; Double-Blind Method; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Humans; Interneurons; Lorazepam; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Models, Neurological; Neural Pathways; Neuropsychological Tests; Placebos; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission | 2007 |
70 other study(ies) available for lorazepam and flumazenil
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.
Topics: Animals; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Convulsants; Down-Regulation; Flumazenil; Isoquinolines; Ligands; Lorazepam; Male; Mice; Motor Activity; Receptors, GABA-A | 1992 |
Modification of gamma-aminobutyric acidA receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of aging.
Topics: Aging; Animals; Benzodiazepines; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebellum; Cerebral Cortex; Dose-Response Relationship, Drug; Flumazenil; gamma-Aminobutyric Acid; Kinetics; Lorazepam; Male; Mice; Mice, Inbred Strains; Quinolines; Receptors, GABA-A | 1991 |
Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.
Topics: Alprazolam; Animals; Benzodiazepines; Brain Chemistry; Flumazenil; Lorazepam; Male; Mice; Receptors, GABA-A | 1990 |
Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys.
Topics: Administration, Inhalation; Alprazolam; Animals; Anti-Anxiety Agents; Appetite Depressants; Benzodiazepines; Buspirone; Carbolines; Carbon Dioxide; Drug Therapy, Combination; Female; Flumazenil; Lorazepam; Macaca mulatta; Male; Pentobarbital; Plethysmography; Pyrazoles; Respiration | 1990 |
Flumazenil therapy in benzodiazepine self-poisoning.
Topics: Adult; Diazepam; Female; Flumazenil; Humans; Lorazepam; Middle Aged; Poisoning | 1991 |
Unusual behavioral profile of alprazolam in squirrel monkeys.
Topics: Alprazolam; Animals; Azides; Benzodiazepines; Dose-Response Relationship, Drug; Electroshock; Flumazenil; Injections, Intravenous; Lorazepam; Male; Psychomotor Performance; Saimiri | 1990 |
Benzodiazepine withdrawal syndrome after a benzodiazepine antagonist.
Topics: Adolescent; Akathisia, Drug-Induced; Diazepam; Drug Overdose; Flumazenil; Humans; Injections, Intravenous; Intubation, Gastrointestinal; Lorazepam; Male; Psychomotor Agitation; Substance Withdrawal Syndrome; Therapeutic Irrigation; Thiopental | 1990 |
Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.
Topics: Animals; Binding Sites; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Chlorides; Drug Tolerance; Flumazenil; Flunitrazepam; Ion Channels; Lorazepam; Male; Mice; Motor Activity; Muscimol; Receptors, GABA-A; Time Factors | 1988 |
Behavioral studies with the beta-carboline FG 7142 combined with related drugs in monkeys.
Topics: Animals; Appetite Depressants; Behavior, Animal; Benzodiazepines; Carbolines; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; Lorazepam; Male; Pyrazoles; Reinforcement Schedule; Saimiri | 1989 |
[Antagonism of the effects of midazolam by flumazenil on the consumption of oxygen by the body].
Topics: Anesthesia; Flumazenil; Humans; Lorazepam; Midazolam; Oxygen Consumption; Postoperative Period; Preanesthetic Medication | 1989 |
Effect of GABAergic drugs on motor impairment from ethanol, barbital and lorazepam in rat lines selected for differential sensitivity to ethanol.
Topics: Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Ethanol; Female; Flumazenil; GABA Antagonists; gamma-Aminobutyric Acid; Isoniazid; Lorazepam; Picrotoxin; Psychomotor Performance; Rats | 1989 |
Drug interactions and clinical pharmacokinetics of flumazenil.
Topics: Anti-Anxiety Agents; Benzodiazepines; Biological Availability; Drug Interactions; Ethanol; Flumazenil; Flunitrazepam; Half-Life; Humans; Liver; Lorazepam; Midazolam; Receptors, GABA-A; Tomography, Emission-Computed | 1988 |
Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Benzodiazepinones; Buspirone; Discrimination Learning; Flumazenil; Isoxazoles; Lorazepam; Male; Papio; Piperazines; Pyrazoles; Pyridazines; Pyrimidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1986 |
The effects of Ro 15-1788 on anxiolytic self-administration in the rhesus monkey.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Drug Interactions; Female; Flumazenil; Flurazepam; Lorazepam; Macaca mulatta; Male; Pentobarbital; Reinforcement, Psychology; Self Administration | 1986 |
Behavioral effects of the beta-carboline derivatives ZK 93423 and ZK 91296 in squirrel monkeys: comparison with lorazepam and suriclone.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Carbolines; Electroshock; Flumazenil; Lorazepam; Male; Naphthyridines; Piperazines; Receptors, GABA-A; Saimiri; Sulfur Compounds | 1987 |
Flumazenil and benzodiazepine withdrawal.
Topics: Animals; Anxiety; Benzodiazepines; Flumazenil; Lorazepam; Male; Mice; Rats; Rats, Inbred Strains; Receptors, GABA-A; Substance Withdrawal Syndrome | 1987 |
Effects of the novel benzodiazepine agonist quazepam on suppressed behavior of monkeys.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Conditioning, Operant; Dose-Response Relationship, Drug; Flumazenil; Lorazepam; Male; Quinazolines; Reinforcement Schedule; Saimiri | 1988 |
Benzodiazepines for catatonic symptoms, stupor, and mutism.
Topics: Anti-Anxiety Agents; Benzodiazepines; Catatonia; Depressive Disorder; Diazepam; Female; Flumazenil; Humans; Lorazepam; Mutism | 1988 |
A late-appearing benzodiazepine-induced hypoactivity that is not reversed by a receptor antagonist.
Topics: Animals; Benzodiazepinones; Brain; Drug Interactions; Flumazenil; Lorazepam; Male; Motor Activity; Rats; Receptors, GABA-A; Substance Withdrawal Syndrome; Time Factors | 1986 |
Mice and rats are sensitized to the proconvulsant action of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam.
Topics: Animals; Benzodiazepinones; Carbolines; Convulsants; Drug Interactions; Flumazenil; Injections, Intraperitoneal; Lorazepam; Mice; Rats; Receptors, GABA-A; Species Specificity; Time Factors | 1986 |
Benzodiazepine receptor occupancy in vivo: correlation with brain concentrations and pharmacodynamic actions.
Topics: Animals; Cerebral Cortex; Clonazepam; Dose-Response Relationship, Drug; Flumazenil; Lorazepam; Male; Mice; Receptors, GABA-A; Time Factors | 1987 |
Chronic treatment with lorazepam and FG 7142 may change the effects of benzodiazepine receptor agonists, antagonists and inverse agonists by different mechanisms.
Topics: Animals; Carbolines; Drug Interactions; Drug Tolerance; Female; Flumazenil; Lorazepam; Mice; Pentylenetetrazole; Receptors, GABA-A | 1987 |
Rapid increase in brain benzodiazepine receptor binding following defeat stress in mice.
Topics: Adrenalectomy; Animals; Brain; Cerebral Cortex; Clonazepam; Flumazenil; Lorazepam; Male; Mice; Receptors, GABA-A; Species Specificity; Stress, Psychological; Time Factors | 1987 |
Acute tolerance to diazepam induced by benzodiazepines.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Flumazenil; Lorazepam; Male; Mice; Sleep | 1986 |
Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.
Topics: Animals; Behavior, Animal; Benzodiazepinones; Brain Chemistry; Carbolines; Drug Interactions; Drug Tolerance; Exploratory Behavior; Flumazenil; Lorazepam; Male; Rats; Social Behavior | 1986 |
Behavioral effects of the pyrazoloquinoline CGS 9896: agonist and antagonist actions in squirrel monkeys.
Topics: Animals; Azabicyclo Compounds; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; Lorazepam; Male; Piperazines; Pyrazoles; Saimiri | 1987 |
Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788.
Topics: Adult; Carbamazepine; Coma; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Flumazenil; Humans; Lorazepam; Mutism | 1987 |
Does the behavioural activation detected after a single dose of a benzodiazepine reflect a withdrawal response?
Topics: Animals; Behavior, Animal; Benzodiazepines; Flumazenil; Lorazepam; Male; Mice; Motor Activity; Oxazepam | 1988 |
Rapid induction of lorazepam dependence and reversal with flumazenil.
Topics: Animals; Carbolines; Flumazenil; Lorazepam; Male; Mice; Mice, Inbred Strains; Seizures; Substance-Related Disorders | 1988 |
Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Drug Tolerance; Exploratory Behavior; Flumazenil; Lorazepam; Male; Motor Activity; Rats | 1982 |
Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; Generalization, Response; Lorazepam; Male; Papio; Pentobarbital | 1983 |
Differential effects of the benzodiazepine antagonist Ro 15-1788 on two types of myoclonus in baboon Papio papio.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepinones; Flumazenil; gamma-Aminobutyric Acid; Light; Lorazepam; Myoclonus; Papio; Seizures | 1983 |
Benzodiazepine selectively antagonize kainate-induced activation in the rat hippocampus.
Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Benzodiazepinones; Chlorpromazine; Diazepam; Flumazenil; Glutamates; Hippocampus; Injections, Intravenous; Iontophoresis; Kainic Acid; Lorazepam; Male; Phenobarbital; Pyramidal Tracts; Pyrrolidines; Rats; Rats, Inbred Strains | 1983 |
Bidirectional effects of benzodiazepine receptor ligands against picrotoxin- and pentylenetetrazol-induced seizures.
Topics: Animals; Anticonvulsants; Benzodiazepinones; Brain; Convulsants; Dose-Response Relationship, Drug; Flumazenil; Lorazepam; Male; Muridae; Pentylenetetrazole; Picrotoxin; Receptors, Cell Surface; Receptors, GABA-A; Seizures | 1983 |
[In vivo study of benzodiazepine receptors using positron emission tomography].
Topics: Animals; Benzodiazepinones; Binding, Competitive; Brain; Chlordiazepoxide; Flumazenil; Flunitrazepam; Kinetics; Lorazepam; Male; Papio; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Neurotransmitter; Stereoisomerism | 1983 |
Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896.
Topics: Animals; Benzodiazepinones; Flumazenil; Humans; Lorazepam; Male; Papio; Pyrazoles; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Cats; Diazepam; Female; Flumazenil; Humans; Lorazepam; Male; Mice; Rats; Saimiri; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1982 |
Benzodiazepine receptors mediate regional blood flow changes in the living human brain.
Topics: Adult; Affect; Brain; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Flumazenil; Functional Laterality; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Humans; Kinetics; Lorazepam; Male; Organ Specificity; Oxygen Radioisotopes; Receptors, GABA-A; Reference Values; Regional Blood Flow; Time Factors; Tomography, Emission-Computed | 1995 |
Depression of thalamic metabolism by lorazepam is associated with sleepiness.
Topics: Adult; Cognition; Deoxyglucose; Depression, Chemical; Flumazenil; Fluorodeoxyglucose F18; Glucose; Humans; Lorazepam; Male; Middle Aged; Occipital Lobe; Sleep; Thalamus; Tomography, Emission-Computed | 1995 |
Flumazenil reversal of benzodiazepine sedation before electroconvulsive therapy.
Topics: Adult; Electroconvulsive Therapy; Female; Flumazenil; Humans; Lorazepam; Male | 1995 |
Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
Topics: Alprazolam; Animals; Anticonvulsants; Brain Chemistry; Cerebral Cortex; Down-Regulation; Drug Tolerance; Flumazenil; Hippocampus; Lorazepam; Male; Mice; Pentylenetetrazole; Receptors, GABA-A; Seizures | 1993 |
Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Binding, Competitive; Conditioning, Operant; Dose-Response Relationship, Drug; Flumazenil; Lorazepam; Male; Mice; Receptors, GABA-A; Reinforcement Schedule | 1994 |
Flumazenil reversal of benzodiazepine-induced sedation for a patient with severe pre-ECT anxiety.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Electroconvulsive Therapy; Flumazenil; Humans; Lorazepam; Male; Midazolam; Schizophrenia | 1994 |
Combination of buspirone and other drugs with beta-CCE in monkeys: effects on respiration and behavior.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Buspirone; Carbolines; Carbon Dioxide; Conditioning, Operant; Drug Interactions; Female; Flumazenil; Lorazepam; Macaca mulatta; Male; Pyridazines; Respiration; Respiratory Mechanics; Tidal Volume | 1993 |
Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination.
Topics: Animals; Anti-Anxiety Agents; Arousal; Buspirone; Cocaine; Discrimination Learning; Dose-Response Relationship, Drug; Eating; Flumazenil; Isoindoles; Lorazepam; Male; Motor Skills; Neurologic Examination; Papio; Pentobarbital; Piperazines; Pyrimidines; Reinforcement Schedule; Self Administration; Serotonin Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Flumazenil as a diagnostic tool in the differential diagnosis of coma in a critically ill patient.
Topics: Aged; Bacterial Infections; Coma; Critical Illness; Diagnosis, Differential; Diazepam; Flumazenil; Hepatic Encephalopathy; Humans; Lorazepam; Male; Midazolam | 1994 |
Flumazenil: an antidotal anecdote.
Topics: Aged; Drug Overdose; Female; Flumazenil; Humans; Lorazepam | 1994 |
[123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain.
Topics: Adult; Animals; Binding, Competitive; Brain; Dialysis; Female; Flumazenil; gamma-Aminobutyric Acid; Half-Life; Humans; Hypnotics and Sedatives; Iodine Radioisotopes; Lorazepam; Male; Nipecotic Acids; Ovariectomy; Papio; Receptors, GABA-A; Tiagabine; Tomography, Emission-Computed, Single-Photon | 1993 |
Solubilized benzodiazepine receptors for use in receptor assays.
Topics: Adsorption; Animals; Binding, Competitive; Brain; Cattle; Cell Membrane; Charcoal; Filtration; Flumazenil; GABA Modulators; In Vitro Techniques; Lorazepam; Polyethylene Glycols; Protein Binding; Radioligand Assay; Receptors, GABA-A; Solubility; Spectrometry, Fluorescence | 1996 |
Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat.
Topics: Animals; Anxiety; Atrial Natriuretic Factor; Behavior, Animal; Drug Interactions; Feeding Behavior; Flumazenil; GABA Modulators; Injections, Intraventricular; Isatin; Lorazepam; Male; Postural Balance; Rats; Rats, Wistar; Social Behavior | 1996 |
Benzodiazepine receptor function in the chick social separation-stress procedure.
Topics: Alprazolam; Analgesia; Animals; Anti-Anxiety Agents; Chickens; Chlordiazepoxide; Disease Models, Animal; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Lorazepam; Receptors, GABA-A; Social Behavior; Stress, Psychological | 1999 |
3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists.
Topics: Amino Acid Substitution; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Flumazenil; GABA Antagonists; GABA Modulators; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Hydroxysteroids; Lorazepam; Oocytes; Patch-Clamp Techniques; Pregnanes; Pregnenolone; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Structure-Activity Relationship; Synapses; Xenopus laevis | 2002 |
Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats.
Topics: Animals; Anxiety; Blotting, Western; Female; Flumazenil; GABA Modulators; Hippocampus; Lorazepam; Male; Membrane Potentials; Motor Activity; Patch-Clamp Techniques; Progesterone; Pyramidal Cells; Rats; Receptors, GABA-A; Sex Characteristics; Substance Withdrawal Syndrome | 2002 |
5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Central Nervous System Depressants; Chlordiazepoxide; Conflict, Psychological; Conscious Sedation; Convulsants; Drug Interactions; Ethanol; Flumazenil; GABA Modulators; Imidazoles; Lorazepam; Male; Mice; Motor Activity; Pentylenetetrazole; Postural Balance; Pyridones; Rats; Rats, Long-Evans; Receptors, GABA-A; Saimiri; Seizures | 2002 |
Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats.
Topics: Acoustic Stimulation; Aging; Animals; Anti-Anxiety Agents; Anxiety; Exploratory Behavior; Female; Flumazenil; GABA Modulators; Lorazepam; Male; Pregnanolone; Progesterone; Rats; Rats, Long-Evans; Receptors, GABA-A; Reflex, Startle; Sex Characteristics | 2003 |
Flumazenil reversal of lorazepam-induced acute delirium.
Topics: Anti-Anxiety Agents; Antidotes; Delirium; Flumazenil; Humans; Lorazepam; Male; Middle Aged | 2003 |
Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.
Topics: Animals; Azides; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Cerebellum; Flumazenil; Humans; Isotope Labeling; Ligands; Lorazepam; Male; Mice; Mice, Transgenic; Prosencephalon; Receptors, GABA-A; Receptors, GABA-B; Tritium | 2005 |
Lorazepam-induced effects on silent period and corticomotor excitability.
Topics: Adult; Anti-Anxiety Agents; Cerebral Cortex; Evoked Potentials, Motor; Flumazenil; Humans; Infusions, Intravenous; Lorazepam; Male; Motor Activity; Reaction Time | 2006 |
Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain gamma-aminobutyric acid(A) receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a]
Topics: Animals; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Flumazenil; Injections, Intravenous; Lorazepam; Male; Positron-Emission Tomography; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2007 |
Changes in relative potency among positive GABA(A) receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys.
Topics: Animals; Behavior, Animal; Benzodiazepines; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Modulators; Lorazepam; Macaca mulatta; Male; Midazolam; Pentobarbital; Pregnanediones; Pregnanolone; Receptors, GABA-A; Substance Withdrawal Syndrome | 2007 |
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Flumazenil; Gene Expression; Hypnotics and Sedatives; Hypothalamo-Hypophyseal System; Lorazepam; Male; Neurons; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; RNA, Heterogeneous Nuclear; Stress, Physiological; Substance Withdrawal Syndrome; Substance-Related Disorders | 2007 |
Neonatal allopregnanolone increases novelty-directed locomotion and disrupts behavioural responses to GABA(A) receptor modulators in adulthood.
Topics: Animals; Animals, Newborn; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Flumazenil; GABA Modulators; Isoxazoles; Lorazepam; Male; Maze Learning; Midazolam; Motor Activity; Pregnanolone; Rats; Rats, Wistar; Receptors, GABA-A | 2009 |
Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration.
Topics: Adult; Benzodiazepines; Catatonia; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Flumazenil; GABA Modulators; Humans; Lorazepam; Obsessive-Compulsive Disorder | 2012 |
Stability of intraocular pressure after retinal reattachment surgery during electroconvulsive therapy for intractable self-injury in a 12-year-old autistic boy.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Autistic Disorder; Child; Electroconvulsive Therapy; Flumazenil; GABA Modulators; Haloperidol; Humans; Hypnotics and Sedatives; Intraocular Pressure; Lorazepam; Male; Ophthalmologic Surgical Procedures; Psychomotor Agitation; Retinal Detachment; Self-Injurious Behavior | 2014 |
Benzodiazepine poisoning in elderly.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidotes; Benzodiazepines; Bromazepam; Cohort Studies; Coma; Diazepam; Drug Overdose; Female; Flumazenil; Humans; Incidence; Length of Stay; Lorazepam; Male; Middle Aged; Pneumonia, Aspiration; Respiratory Insufficiency; Retrospective Studies; Serbia; Suicide, Attempted; Young Adult | 2016 |